Pharmaceuticals Research This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 21.

A look at drug firms’ outsourcing practices
A new study shows top drug companies outsource 75 percent or more of the health economics workload. Research Triangle Park-based Cutting Edge Information finds that, as health economics and outcomes research – or HEOR – teams take on a greater role within pharma, outsourcing is an attractive way to maximize resources. Small pharma companies take it further, outsourcing 93 percent of their HEOR work.
Source: bizjournals.com Health Care:Biotechnology headlines - September 27, 2012 Category: Biotechnology Authors: Lauren K. Ohnesorge Source Type: research

Simulation laboratory idea still being developed
While an upcoming Business First story will analyze the increased interest from educational institutions in the Buffalo Niagara Medical Campus, it's worth noting that the push for a simulation laboratory on the medical campus is still on. Credit for the idea goes to Arup Sen, vice president of academic affairs at D'Youville College, who is still its main promoter, though Sen acknowledges it will be an "expensive proposition" and that the funding hasn't yet been identified. The project started out…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 26, 2012 Category: Pharmaceuticals Authors: Dan Miner Source Type: research

Vince & Associates lands $5M FDA contract to study drug side effects
Vince & Associates Clinical Research has received a five-year contract with the Food and Drug Administration that could be worth $5 million. The Overland Park-based contract research organization announced the deal Tuesday. The company will conduct so-called “bioequivalence” studies on generic and branded drugs, such as those treating epilepsy, to see if the substances used in each essentially are the same. Dr. Brad Vince, president and medical director, said in a release that the products…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2012 Category: Pharmaceuticals Authors: David Twiddy Source Type: research

New express bus goes from Weston/Sunrise area to downtown Miami
The 595 Express weekday bus service is expanding Oct. 1 to include a new route from Westgate Square Shopping Center in the Sunrise/Weston area to Miami Civic Center. Service will be free the first week. New hybrid buses on the route offer free Wi-Fi access, 12-volt power outlets for charging electronic equipment and high-back seats for passenger comfort. Complimentary parking at the park-and-ride lot at the southeast corner of Weston Road and SR 84 is available to passengers with a 595 Express…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2012 Category: Pharmaceuticals Source Type: research

New Silver Spring headquarters for Community Clinic
Community Clinic Inc. has signed a lease for a new headquarters and health center in downtown Silver Spring, according to a news release. The federally qualified health center has taken 14,387 square feet in the Montgomery Center at 8630 Fenton St., and moved 20 administrative employees into offices covering half the space. The other half is now under development as a clinic, which will open later this fall and serve roughly 2,000 patients.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2012 Category: Pharmaceuticals Source Type: research

Palm Beach State College gets $4M in job training grants
Palm Beach State College received $3.98 million in federal grants for job training programs. The U.S. Department of Labor grant will help the college boost its health information technology, machining and welding technology programs. The largest grant was $3 million to support its newly launched health information technology associate in science degree and a related certificate program. The other $975,000 was part of a $15 million grant to 12 Florida colleges, including Broward College, for manufacturing…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2012 Category: Pharmaceuticals Authors: Brian Bandell Source Type: research

Holy Cross Hospital to reorganize as system
Holy Cross Hospital will re-organize its corporate structure and rename itself Holy Cross Health, according to the Silver Spring nonprofit. Underneath the corporate banner, the new system will have three operating divisions led by presidents, who will report to a chief executive officer: Holy Cross Hospital, Holy Cross Germantown Hospital and Holy Cross Health Network, which will include the hospital's three low-income health centers, its network of employed physicians and insurance relations. Longtime…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2012 Category: Pharmaceuticals Authors: Ben Fischer Source Type: research

Business economists vs. Obama and Romney
Two economic advisers to President Barack Obama and Republican challenger Mitt Romney squared off Monday before the National Association for Business Economics. The result was a predictable partisan squabble. Here's what Obama adviser Jeffrey Liebman, professor of public policy at Harvard University, had to say about Romney's plan to cut taxes on everyone -- without increasing the deficit: "The numbers just don't add up." Here's what Romney adviser Kevin Hassett, director of economy policy studies…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2012 Category: Pharmaceuticals Authors: Kent Hoover Source Type: research

Andrew Carter named HAP president
Andrew Carter has been named president and CEO of the Hospital & Healthsystem Association of Pennsylvania, replacing Carolyn Scanlan who is retiring. Carter’s appointment is effective Dec. 12 and Scanlan will retire Dec. 31 after nearly 18 years with the Harrisburg-based trade group. Carter comes to HAP from Washington D.C.-based Visiting Nurse Associations of America, where he has served as president and CEO since 2007. He was president of the Ohio Children’s Hospital Association between 2001…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2012 Category: Pharmaceuticals Authors: Kris B. Mamula Source Type: research

UC Davis cancer center expansion consolidates care, research
After 10 years of planning, the UC Davis Comprehensive Cancer Center opened a $33 million new wing to patients Monday, Kathy Robertson writes. The 46,000-square-foot expansion responds to increased demand and brings clinical care and research programs, patients and providers under one roof. The integration of programs will help streamline operations, improve patient access to clinical trials and enhance collaboration among clinical and research faculty. A slideshow features the newly opened expansion.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2012 Category: Pharmaceuticals Source Type: research

Website helps businesses sort through health care rules
Employers face new federal requirements when they renew coverage or enroll new people into plans this fall, but there’s a resource to help wade through the rules, Kathy Robertson writes in her blog. Effective Sept. 23, employers and health insurers must provide employees or consumers a uniform glossary and easy-to-understand summary of benefits and coverage. What employers need to think about and do to comply is explained by the Health Law Guide for Business, a website created by top California…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2012 Category: Pharmaceuticals Source Type: research

Oishei makes $10M pledge to new children's hospital
Kaleida Health announced Tuesday that it will receive a $10 million gift from the John R. Oishei Foundation as part of the construction of a new children’s hospital on the Buffalo Niagara Medical Campus. Additional details are to come on the partnership. Plans call for a ground-breaking next year for the $200 million facility. The 430,000-square-foot building will go up at the corner of High and Ellicott streets, to be connected to Buffalo General Medical Center and the Gates Vascular Institute…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2012 Category: Pharmaceuticals Authors: Tracey Drury Source Type: research

A new non-invasive approach based on polyhexamethylene biguanide increases the regression rate of HPV infection
Conclusions: The topic treatment with PHMB is a preliminary safe and promising approach for patients with detected HPV infection increasing the chance of clearance and avoiding the use of invasive treatments when not strictly necessary.Trial registrationClinicalTrials.gov Identifier NCT01571141
Source: BMC Clinical Pathology - Latest articles - September 25, 2012 Category: Pathology Authors: Antonio GentileSandro GerliGian Carlo Di Renzo Source Type: research

Former health-care billing firm supervisor pleads guilty to bank fraud
Pamela Hoernschemeyer, 46, of St. Peters, a former supervisor at Lackland Acquisition II LLC, pleaded guilty Monday to bank fraud charges related to submitting more than $100,000 in fraudulent check requests while she was an insurance billing supervisor handling the company's SSM Health Care account. Lackland Acquisition, doing business as Healthcare Strategic Initiatives (HSI) and operating as Nextgen Healthcare, contracted with SSM to provide the health system with patient billing and collections,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2012 Category: Pharmaceuticals Authors: Greta Weiderman Source Type: research

Cambia's John Morgan to head Avamere
John Morgan, one of Cambia Health Solutions' top executives, is leaving to become CEO of the Avamere Family of Cos., which operates assisted living facilities. Morgan is president of Direct Health Solutions, a venture capital arm of Cambia that's key to its shift from traditional health insurance to becoming a "health solutions company." He will rejoin Cambia's board of directors after his last day at Direct Health Solutions on Sept. 30. He previously served on Cambia's board while he was CEO of…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2012 Category: Pharmaceuticals Authors: Matthew Kish Source Type: research

CNS Therapeutics sold to Covidien for $100M
CNS Therapeutics Inc. has been sold to Covidien's pharmaceuticals business in a deal worth about $100 million. St. Paul-based CNS develops treatments for central nervous system disorders. It received regulatory approval in 2010 to market its first product: Gablofen, a generic version of the drug Lioresal, which is used to treat a condition called severe spasticity. The drug is delivered directly to an area of a patient's spine via an implantable drug pump made by Fridley-based Medtronic Inc. (NYSE:…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2012 Category: Pharmaceuticals Authors: Katharine Grayson Source Type: research

HyperBranch Medical starting new trial for sealant
Durham-based HyperBranch Medical Technology is one step closer in getting its new surgical sealant to market. The company announced it has completed patient enrollment in neurosurgery trials for Adherus Dural Sealant. The more than 240 patients treated will be followed for four months to evaluate the sealant’s safety and effectiveness, and then the data will be submitted to the Food and Drug Administration. The company has already been marketing its bioadhesive spray sealant, which has been commercially…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2012 Category: Pharmaceuticals Authors: Lauren K. Ohnesorge Source Type: research

Paraquad In-Home Services employee indicted for Medicaid fraud
A grand jury in city of St. Louis Circuit Court has indicted Ruth Ann Fair, 58, a personal care services attendant in St. Louis, on four felony counts of Medicaid fraud, Missouri Attorney General Chris Koster said. Fair is accused of presenting false timesheets to her employer, Paraquad In-Home Services Inc., a St. Louis Medicaid provider. Based on those timesheets, Medicaid was improperly billed for more than $6,500, Koster said. Fair has been charged with four class C felonies. Those charges,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2012 Category: Pharmaceuticals Authors: Greta Weiderman Source Type: research

Kraus-Anderson starts work on large HealthPartners clinic
Kraus-Anderson Construction Co. said Monday it has started construction on a HealthPartners Inc. clinic in Anoka. The 60,000-square-foot HealthPartners Riverway Clinic is scheduled to open next July, Minneapolis-based Kraus-Anderson said in a news release. >A rendering of the Anoka building is to the right. >>>>> The building is two stories high and is located at the former Castle Field at 601 Jacob Lane. Meanwhile, Kraus-Anderson said it is nearing completion on another building…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2012 Category: Pharmaceuticals Authors: Ed Stych Source Type: research

Investors dismiss lawsuit against Centene, executives
A group of investors have dropped a class-action lawsuit filed June 29 against Centene Corp. that alleged the company misrepresented its financial condition. Boca Raton, Fla.-based Saxena White PA had filed the lawsuit in U.S. District Court in St. Louis on behalf of investors who purchased Centene common stock between Feb. 7 and June 8. Local counsel was James Rosemergy of Carey, Danis & Lowe in St. Louis. The plaintiff filed a motion Sept. 21 to voluntarily dismiss the lawsuit as to all claims…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2012 Category: Pharmaceuticals Authors: Greta Weiderman Source Type: research

Cellceutix to launch cancer trial after delay
Cellceutix Corporation (OTCBB: CTIX) will launch its first human trial for its lead product, a potential therapy for advanced solid tumors, at Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center after a nine-month delay. In January, the Beverly, Mass.-based biotechnology company was hit with what’s called a “clinical hold” by the U.S. Food and Drug Administration, due to manufacturing problems at Cellceutix’ manufacturing partner, Andover-Mass.-based Formatech. Formatech…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2012 Category: Pharmaceuticals Authors: Julie M. Donnelly Source Type: research

Former Florida Gov. Jeb Bush keynotes BioFlorida conference
Jeb Bush, former governor of Florida, will kick off the upcoming conference of BioFlorida with a post-breakfast keynote session on Oct. 8. Bush is credited with advancing and growing Florida’s bioscience industry during his term in office, a statement said. BioFlorida, the voice of Florida’s bioscience industry, will hold this year’s conference Oct. 7-Oct. 9 in Miami.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2012 Category: Pharmaceuticals Source Type: research

Chicago Symphony Orchestra musicians call strike as management digs in
Ticket holders were blindsided Saturday night when members of the Chicago Symphony Orchestra suddenly called a strike just an hour before the orchestra was to perform a concert with CSO music director Riccardo Muti conducting. The strike, which was still ongoing Monday, is the second high-profile labor dispute in Chicago just this month. A bitter, seven day teachers strike ended last week with both sides declaring a victory of sorts. For weeks, Chicago media outlets detailed every little twist…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2012 Category: Pharmaceuticals Authors: Lewis Lazare Source Type: research

Chemists Crank Up Heat On Microwaves
No longer a lab curiosity, microwave-assisted reactions are making headway in pharma and nanomaterials labs
Source: NanoFocus - September 24, 2012 Category: Nanotechnology Authors: Stephen K. Ritter Source Type: research

Romney: $1.9M in 2011 taxes; 14.1% rate
It took a while, but Republican presidential nominee Mitt Romney today finally released his 2011 federal income tax return: He paid $1.9 million in taxes on income of $13.7 million, mostly from investments. That's an effective tax rate of 14.1 percent. Romney and his wife made $4 million in charitable contributions last year, but deducted only $2.25 million of them. The Romney campaign also released a summary of Romney's taxes from 1990 to 2009. His average effective tax rate over this span was…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2012 Category: Pharmaceuticals Authors: Kent Hoover Source Type: research

Astex dumps experimental lung cancer drug
Astex Pharmaceuticals Inc. has discontinued its work to bring an experimental cancer drug through clinical trials and onto the market, the company said Friday. The Dublin-based company (NASDAQ: ASTX) said it will try to license the drug -- called amuvatinib, or MP-470 -- which was in the second phase of the three-part clinical trial process. The Phase II trial looked at the drug as a treatment for small cell lung cancer. "We have decided to end the clinical development of amuvatinib despite the…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2012 Category: Pharmaceuticals Authors: Ron Leuty Source Type: research

European panel recommends Avastin for type of ovarian cancer patients
Avastin, the world's best-selling cancer drug from Swiss drug maker Roche, received a positive opinion Friday from a European Union group to treat a subset of ovarian cancer patients. The Committee for Medicinal Products for Human Use, or CHMP, essentially recommended that EU authorities approve Avastin in combination with the chemotherapy agents carboplatin and gemcitabine to treat women with recurrent, platinum-sensitive ovarian cancer, the company said Friday. Avastin was developed by South…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2012 Category: Pharmaceuticals Authors: Ron Leuty Source Type: research

Romney paid $1.9 million in taxes in 2011; 14.1% effective rate
It took a while, but Republican presidential nominee Mitt Romney today finally released his 2011 federal income tax return: He paid $1.9 million in taxes on income of $13.7 million, mostly from investments. That's an effective tax rate of 14.1 percent. Romney and his wife made $4 million in charitable contributions last year, but deducted only $2.25 million of them. The Romney campaign also released a summary of Romney's taxes from 1990 to 2009. His average effective tax rate over this span was…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2012 Category: Pharmaceuticals Authors: Kent Hoover Source Type: research

M.D. Anderson's $3B program could drive new life science industry
The University of Texas M.D. Anderson Cancer Center's new $3 billion Moon Shots Program not only is expected to reduce patient mortality rates, but it also could help drive a new industry in Houston, the center's president says. The program, which was announced Friday, will take a more-driven approach utilizing goal-oriented execution platforms to reduce mortality rates of eight types of cancers. M.D. Anderson President Dr. Ronald DePinho said the Houston community is poised to create a life sciences…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2012 Category: Pharmaceuticals Authors: Bayan Raji Source Type: research

Medicare: Who do you trust more, Obama or Romney?
President Barack Obama is leading Republican challenger Mitt Romney on the issue of which candidate is better positioned to address the Medicare system. In the nation’s top 12 battleground states, 50 percent of voters said they trust Obama more than Romney on Medicare, but 53 percent are pessimistic that Medicare will still provide all Americans over 65 with health care coverage 20 years from now, according to the USA Today/Gallup poll. Romney has criticized Obama for federal health reform, which…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2012 Category: Pharmaceuticals Authors: Annie Johnson Source Type: research

Aurora, Northwestern Mutual, Marquette react to steam rate increases
An increase in steam costs for downtown buildings proposed by the Citizens Utility Board would hurt efforts to stem losses at Aurora Sinai Medical Center and weigh into Northwestern Mutual’s decision on whether to move to Franklin. That is according to testimony downtown Milwaukee businesses filed Thursday with the Public Service Commission of Wisconsin. The testimony is part of a We Energies rate increase case. The steam from We Energies’ Menomonee Valley power plant heats most downtown buildings.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2012 Category: Pharmaceuticals Authors: Sean Ryan Source Type: research

Study: Primary-care docs make less than specialists
Earnings over the course of careers of primary-care doctors average as much as $2.8 million less than the earnings of their specialist colleagues, according to a new study by UC Davis researchers. The wage disparity may make primary care a less attractive choice for medical-school graduates, exacerbate an already significant shortage of primary-care doctors and hamper access to care under federal health reform, study leaders suggested. In response, they recommend reducing disparities in physician…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2012 Category: Pharmaceuticals Authors: Kathy Robertson Source Type: research

IdeaFestival: Future of health lies in preventive care, Humana executive says
The future of health, in the United States and around the globe, will come down to prevention and preparation, according to Shankar Ram, vice president of innovation at Humana Inc. “It’s obvious that health care has a huge impact on the economy,” he said. “Reactive medicine is going to be expensive.” The challenge for companies like Humana is getting individuals to embrace positive behavioral change, he said during a Friday morning panel discussion of the future of health and longevity…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2012 Category: Pharmaceuticals Authors: David A. Mann Source Type: research

Target drug wholesaler McKesson charged with artificially inflating prescription prices
The drug wholesaler that stocks Target Corp.’s pharmacy shelves is being sued by the state of Arizona, which claims the company has violated state laws by artificially inflating prices of more than 400 brand-name prescriptions. The Phoenix Business Journal reports that the complaint filed by the Arizona Attorney General alleges McKesson Corp., the nation’s largest drug wholesaler, began a price inflation scheme in 2000 that has cost Arizona consumers millions. McKesson could not be reached for…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2012 Category: Pharmaceuticals Authors: Kyle Potter Source Type: research

A Feasibility Study on Pellet Coating Using a High-Speed Quasi-continuous Coater.
This study investigated the feasibility of pellet coating in a newly developed coater built with a unique airflow system, the Supercell™ coater (GEA Pharma Systems, UK). A full factorial design study was carried out to evaluate the influences of the spray rate of the coating dispersion, batch size of the pellet load, pellet size fraction and plenum pressure of the fluidizing air on the color coating of pellets in the Supercell™ coater. Results showed that pellets could be successfully coated using the Supercell™ coater. Higher plenum pressures and lower spray rates were found to minimize pellet agglomeration during c...
Source: AAPS PharmSciTech - September 21, 2012 Category: Drugs & Pharmacology Authors: Cahyadi C, Koh JJ, Loh ZH, Chan LW, Heng PW Tags: AAPS PharmSciTech Source Type: research

Excela Health loses chief medical officer
Dr. Jerome Granato has resigned from Excela Health as chief medical officer, less than two years after being named to the position. Excela Health spokeswoman Jennifer Miele said late Thursday that Granato resigned Sept. 14. She declined to specify reasons for his departure and Granato was unavailable for comment. “We truly appreciate the great strides Dr. Granato made at Excela Health in quality and patient care at Excela,” Miele said. “And we wish him the very best.” Granato was named…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 20, 2012 Category: Pharmaceuticals Authors: Kris B. Mamula Source Type: research

PBN honors Hawaii’s Healthiest Employers: Slideshow
Castle Medical Center, Bowers + Kubota Consulting and Hawaii Human Resources were honored as PBN’s Healthiest Employers in Hawaii Thursday during a luncheon program at the Sheraton Waikiki. The companies were each honored in a category based on the number of employees for their efforts to promote health and wellness in the workplace. The winners were chosen by the Mainland-based wellness technology company Healthiest Employers, which measures six aspects of wellness programming with an online…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 20, 2012 Category: Pharmaceuticals Source Type: research

Successful workplace health and wellness programs need support from the top
In order to have successful health and wellness programs in the workplace, Hawaii business leaders need to create a culture that supports them. Creating a healthy workplace needs to start with support from the top, with employee buy-in at all levels of the organization, a panel of experts said at PBN’s health and wellness breakfast seminar at the Sheraton Waikiki Thursday before PBN’s Healthiest Employers luncheon. Doing so, they said, leads to healthier employees and a healthier company that…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 20, 2012 Category: Pharmaceuticals Authors: Stephanie Silverstein Source Type: research

Health exchange reconsidering stance on stand-alone vision plans
Stand-alone vision plans may not barred from selling to individuals through the California Health Benefit Exchange after all. Making no promises, executive director Peter Lee said Tuesday the board expects to revisit the matter at its Oct. 16 meeting. Exchange staff confirmed Wednesday they are in discussions with VSP Global, the company that blasted the Aug. 23 board decision to keep them out of this part of the program for at least a year. Furious over the vote, CEO Rob Lynch suggested in an…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 20, 2012 Category: Pharmaceuticals Authors: Kathy Robertson Source Type: research

Adventist HealthCare to fashion new proposal for White Oak hospital
Washington Adventist Hospital has admitted defeat, for now. The Adventist HealthCare subsidiary on Tuesday withdrew its request for regulatory approval to relocate from Takoma Park to White Oak, according to President Joyce Newmyer. The decision comes two weeks after a member of the Maryland Health Care Commission recommended the full commission reject the $398 million proposal because of doubts of its cost-effectiveness.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2012 Category: Pharmaceuticals Source Type: research

Group names two Winston-Salem health facilities among top performers
Medical Park Hospital and Old Vineyard Behavioral Health Services have been named to the 2012 list of top performers in quality and safety by The Joint Commission, a national hospital accrediting organization. Medical Park, a specialty surgical hospital in Winston-Salem owned by Novant Health, was recognized for surgical care. Old Vineyard, a Winston-Salem-based mental health facility, was selected for hospital-based inpatient psychiatric care. This is the second year the Joint Commission has recognized…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2012 Category: Pharmaceuticals Authors: Owen Covington Source Type: research

Local hospitals recognized by Joint Commission
Three Birmingham hospitals have been recognized by the nation’s leading accreditor of health care organizations as 2011 top performers. The Joint Commission announced today that Princeton Baptist Medical Center, Trinity Medical Center and Brookwood Medical Center were top performers in key quality measures dealing with heart attack, heart failure, pneumonia and surgical care. The designation signifies the hospitals’ programs ranked in the top 18 percent among the more than 19,000 health care…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2012 Category: Pharmaceuticals Authors: Evan Belanger Source Type: research

Procter & Gamble, TriHealth make Working Mother Best 100 Companies list
Procter & Gamble Co. and TriHealth Inc. made Working Mother magazine’s 100 Best Companies list for 2012. The application for the list includes more than 500 questions on work force representation, child care, flexibility programs, leave policies and more. It surveys the availability, usage and tracking of programs, as well as the accountability of managers who oversee them. This year, the magazine gave particular weight to child care, flexible scheduling options and advancement programs. P&G…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2012 Category: Pharmaceuticals Source Type: research

UCSF nets $20M gift for new Mission Bay building
A $20 million gift to UCSF from philanthropist Charles Feeney will help pay for a new building housing the university's global health sciences program while adding to an awesome legacy by the co-founder of Duty Free Shoppers. In all, Feeney's Atlantic Philanthropies has given more than $292 million to the University of California, San Francisco, making him the single largest contributor to any campus in the UC system, the university said, and arguably the granddaddy of UCSF's Mission Bay campus. Atlantic…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2012 Category: Pharmaceuticals Source Type: research

Johnson & Johnson plans intravenous Simponi rheumatoid arthritis drug
Janssen Biotech Inc. has submitted a biologics license application to the Food and Drug Administration requesting approval of an intravenous formulation of Simponi for the treatment of adults with moderately to severely active rheumatoid arthritis. The Horsham, Pa.-based biotechnology company, a subsidiary of Johnson & Johnson (NYSE:JNJ), received approval for its subcutaneous formulation of Simponi in 2009. The drug is now sold in 57 countries and is available either through the Janssen’s SmartJect…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2012 Category: Pharmaceuticals Authors: John George Source Type: research

Pappas-backed CoLucid gets FDA accord
Durham-based CoLucid Pharmaceuticals, Inc. has reached an agreement with the U.S. Food and Drug Administration’s Division of Neurology Products on the strategy the young pharma will follow in developing its migraine drug candidate. The drug, lasmiditan, is intended for patients with, or at risk of, cardiovascular disease, as well as patients who haven’t gotten help from some other treatments. Six clinical studies have been successfully completed so far, including a Phase 2b double blind placebo…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2012 Category: Pharmaceuticals Authors: Lauren K. Ohnesorge Source Type: research

Vystar buys SleepHealth
Vystar Corp. bought Monroe, Ga.-based sleep diagnostic company SleepHealth LLC for an undisclosed amount. SleepHealth provides sleep lab management services to hospitals and physicians’ offices in the Southeast. It has 27 facilities in North Carolina, South Carolina and Georgia. Duluth, Ga.-based Vystar (OTC BB: VYST) makes Vytex Natural Rubber Latex (NRL) -- a patented, all-natural raw material that reduces antigenic proteins found in natural rubber latex. It recently partnered with Islatex…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2012 Category: Pharmaceuticals Authors: Jacques Couret Source Type: research

Tranzyme hauls in $10.6M
Tranzyme Pharmaceuticals (Nasdaq: TZYM) has closed on a previously announced share offering of approximately three million shares of its common stock at a price of $3.85 per share for gross proceeds, including the over allotment option, of approximately $11.5 million. The net proceeds are about $10.6 million, after fees. The money raised will go toward working capital and other general corporate expenses. Company CEO Vipin Garg says Tranzyme, which focuses on treating gastrointestinal illnesses,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2012 Category: Pharmaceuticals Authors: Lauren K. Ohnesorge Source Type: research

UPMC: Margin makes great care possible
What Pittsburgh native Robert DeMichiei took home from Thanksgiving dinner with his family last year was that money and mission rarely intersect when talk turns to the University of Pittsburgh Medical Center. So, what started out as questions about UPMC’s finances at the DeMichiei dinner table has been transformed into an effort to explain that old axiom of health care finance to Joe Sixpack: no money, no mission. Or in the case of UPMC: a robust balance sheet makes clinical excellence possible. “The…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2012 Category: Pharmaceuticals Authors: Kris B. Mamula Source Type: research

Polls conflict: Survey finds small biz backs Romney, not Obama
Were you surprised by the George Washington University/Thumbtack.com survey that showed small business owners favored President Barack Obama over Republican challenger Mitt Romney? Well, another recent poll found that Romney has a big lead over Obama among small business owners. This poll, conducted by small business software developer Wave Accounting, shows Romney with a 44 percent to 32 percent lead over Obama among small business owners. It's based on a survey of 1,331 Wave customers in the U.S.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 18, 2012 Category: Pharmaceuticals Authors: Kent Hoover Source Type: research